BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29652100)

  • 1. How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countries.
    Stuart RM; Grobicki L; Haghparast-Bidgoli H; Panovska-Griffiths J; Skordis J; Keiser O; Estill J; Baranczuk Z; Kelly SL; Reporter I; Kedziora DJ; Shattock AJ; Petravic J; Hussain SA; Grantham KL; Gray RT; Yap XF; Martin-Hughes R; Benedikt CJ; Fraser-Hurt N; Masaki E; Wilson DJ; Gorgens M; Mziray E; Cheikh N; Shubber Z; Kerr CC; Wilson DP
    J Int AIDS Soc; 2018 Apr; 21(4):e25097. PubMed ID: 29652100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allocative and implementation efficiency in HIV prevention and treatment for people who inject drugs.
    Benedikt C; Kelly SL; Wilson D; Wilson DP;
    Int J Drug Policy; 2016 Dec; 38():73-80. PubMed ID: 27883944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDS.
    Kelly SL; Martin-Hughes R; Stuart RM; Yap XF; Kedziora DJ; Grantham KL; Hussain SA; Reporter I; Shattock AJ; Grobicki L; Haghparast-Bidgoli H; Skordis-Worrall J; Baranczuk Z; Keiser O; Estill J; Petravic J; Gray RT; Benedikt CJ; Fraser N; Gorgens M; Wilson D; Kerr CC; Wilson DP
    Lancet HIV; 2018 Apr; 5(4):e190-e198. PubMed ID: 29540265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In the interests of time: improving HIV allocative efficiency modelling via optimal time-varying allocations.
    Shattock AJ; Kerr CC; Stuart RM; Masaki E; Fraser N; Benedikt C; Gorgens M; Wilson DP; Gray RT
    J Int AIDS Soc; 2016; 19(1):20627. PubMed ID: 26928810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal allocation of HIV resources among geographical regions.
    Kedziora DJ; Stuart RM; Pearson J; Latypov A; Dierst-Davies R; Duda M; Avaliani N; Wilson DP; Kerr CC
    BMC Public Health; 2019 Nov; 19(1):1509. PubMed ID: 31718603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs of providing HIV care and optimal allocation of HIV resources in Guyana.
    Suraratdecha C; Stuart RM; Edwards M; Moore R; Liu N; Wilson DP; Albalak R
    PLoS One; 2020; 15(10):e0238499. PubMed ID: 33119591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optima: A Model for HIV Epidemic Analysis, Program Prioritization, and Resource Optimization.
    Kerr CC; Stuart RM; Gray RT; Shattock AJ; Fraser-Hurt N; Benedikt C; Haacker M; Berdnikov M; Mahmood AM; Jaber SA; Gorgens M; Wilson DP
    J Acquir Immune Defic Syndr; 2015 Jul; 69(3):365-76. PubMed ID: 25803164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the use of modelling in resource allocation decisions for HIV and TB.
    Bowring AL; Ten Brink D; Martin-Hughes R; Fraser-Hurt N; Cheikh N; Scott N
    BMJ Glob Health; 2024 Jan; 9(1):. PubMed ID: 38232992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of constraints on the efficient allocation of resources for HIV prevention.
    Stopard IJ; McGillen JB; Hauck K; Hallett TB
    AIDS; 2019 Jun; 33(7):1241-1246. PubMed ID: 30649065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing HIV/AIDS resources in Armenia: increasing ART investment and examining HIV programmes for seasonal migrant labourers.
    Kelly SL; Shattock AJ; Kerr CC; Stuart RM; Papoyan A; Grigoryan T; Hovhannisyan R; Grigoryan S; Benedikt C; Wilson DP
    J Int AIDS Soc; 2016; 19(1):20772. PubMed ID: 27281790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reorienting the HIV response in Niger toward sex work interventions: from better evidence to targeted and expanded practice.
    Fraser N; Kerr CC; Harouna Z; Alhousseini Z; Cheikh N; Gray R; Shattock A; Wilson DP; Haacker M; Shubber Z; Masaki E; Karamoko D; Görgens M
    J Acquir Immune Defic Syndr; 2015 Mar; 68 Suppl 2():S213-20. PubMed ID: 25723987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The City of Johannesburg can end AIDS by 2030: modelling the impact of achieving the Fast-Track targets and what it will take to get there.
    Stuart RM; Fraser-Hurt N; Kerr CC; Mabusela E; Madi V; Mkhwanazi F; Pillay Y; Barron P; Muzah B; Matsebula T; Gorgens M; Wilson DP
    J Int AIDS Soc; 2018 Jan; 21(1):. PubMed ID: 29359533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kazakhstan can achieve ambitious HIV targets despite expected donor withdrawal by combining improved ART procurement mechanisms with allocative and implementation efficiencies.
    Shattock AJ; Benedikt C; Bokazhanova A; Đurić P; Petrenko I; Ganina L; Kelly SL; Stuart RM; Kerr CC; Vinichenko T; Zhang S; Hamelmann C; Manova M; Masaki E; Wilson DP; Gray RT
    PLoS One; 2017; 12(2):e0169530. PubMed ID: 28207809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimum resource allocation to reduce HIV incidence across sub-Saharan Africa: a mathematical modelling study.
    McGillen JB; Anderson SJ; Dybul MR; Hallett TB
    Lancet HIV; 2016 Sep; 3(9):e441-e448. PubMed ID: 27562745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optima Nutrition: an allocative efficiency tool to reduce childhood stunting by better targeting of nutrition-related interventions.
    Pearson R; Killedar M; Petravic J; Kakietek JJ; Scott N; Grantham KL; Stuart RM; Kedziora DJ; Kerr CC; Skordis-Worrall J; Shekar M; Wilson DP
    BMC Public Health; 2018 Mar; 18(1):384. PubMed ID: 29558915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model for allocating CDC's HIV prevention resources in the United States.
    Lasry A; Sansom SL; Hicks KA; Uzunangelov V
    Health Care Manag Sci; 2011 Mar; 14(1):115-24. PubMed ID: 21184183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applying the 'no-one worse off' criterion to design Pareto efficient HIV responses in Sudan and Togo.
    Stuart RM; Haghparast-Bidgoli H; Panovska-Griffiths J; Grobicki L; Skordis J; Kerr CC; Kedziora DJ; Martin-Hughes R; Kelly SL; Wilson DP
    AIDS; 2019 Jun; 33(7):1247-1252. PubMed ID: 30664007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons learned from stakeholder-driven sustainability analysis of six national HIV programmes.
    Katz I; Glandon D; Wong W; Kargbo B; Ombam R; Singh S; Ramsammy L; Tal-Dia A; Seck I; Osika JS
    Health Policy Plan; 2014 May; 29(3):379-87. PubMed ID: 23612848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optima TB: A tool to help optimally allocate tuberculosis spending.
    Goscé L; Abou Jaoude GJ; Kedziora DJ; Benedikt C; Hussain A; Jarvis S; Skrahina A; Klimuk D; Hurevich H; Zhao F; Fraser-Hurt N; Cheikh N; Gorgens M; Wilson DJ; Abeysuriya R; Martin-Hughes R; Kelly SL; Roberts A; Stuart RM; Palmer T; Panovska-Griffiths J; Kerr CC; Wilson DP; Haghparast-Bidgoli H; Skordis J; Abubakar I
    PLoS Comput Biol; 2021 Sep; 17(9):e1009255. PubMed ID: 34570767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.